Description
The Head, Oncology Clinical Development- ADCs, will report to the SVP, Head of Oncology Clinical Development. The role holder will be accountable for the design and implementation of the clinical development strategy across a particular asset across multiple tumor types spanning early- and late-phase development.
Key Responsibilities & Accountabilities:
- Clinical Development Strategy & Portfolio Leadership:
- Accountable for end-to-end clinical development of an MOA-focused, multi-tumor asset, including registrational trials, regulatory approval, and initial market launch.
- Shape and drive the scientific and clinical development strategy for the asset and disease areas, aligned with Oncology Tumor Team strategy and broader Oncology portfolio priorities.
- Evaluate, champion, and enable the use of novel approaches where they add clear scientific, operational, or decision-making value to clinical development.
- Program Oversight, Governance & Visibility:
- Provide oversight and connectedness across the asset program, maintaining visibility to progress, risks, dependencies, and trade-offs across the Oncology portfolio.
- Serve as the default senior clinical representative at key governance forums for the asset.
- Represent the Oncology Clinical Development organization internally and externally.
- Cross-Functional Leadership & Connector Role:
- Act as a senior connector across functions, partnering closely with Oncology Research, Precision Medicine/Companion Diagnostics, Medical Affairs, Commercial, and Global Product Strategy.
- Drive asset alignment across research, development, and commercialization planning.
- Build and sustain strong internal and external partnerships.
- Culture & Capability Building:
- Foster a culture of empowerment, scientific excellence, inclusion, and collaboration.
- Actively remove organizational barriers and enable teams to operate effectively and autonomously.
- Standards, Processes & Continuous Improvement:
- Contribute to the establishment and continuous evolution of clinical development standards, processes, and best practices across Oncology.
- Ensure timely access to relevant external scientific and competitive intelligence.
Skills & Capabilities:
- Senior clinical and scientific leadership in early- and late-phase oncology drug development.
- Strong ability to translate science and translational insight into differentiated clinical development strategies.
- Proven capability to operate at portfolio level, balancing priorities, risk, and resources.
- Credibility and effectiveness representing Clinical Development at senior governance forums.
- Advanced cross-functional and matrix leadership skills.
Basic Qualifications:
- Medical degree (MD, MBBS, MBChB or international equivalent).
- Board certification/eligibility or registration in a primary or medical specialty.
- Oncology drug development experience in the pharmaceutical industry.
- Leadership experience of early- and focused late-phase oncology development programs.
- Experience leading Antibody Drug Conjugate or other targeted oncology development programs.
Preferred Qualifications:
- Board certification/eligibility or registration in medical oncology, hematology/oncology.
- Strong experience in governance leadership, scientific narrative ownership, portfolio influence, and executive-level decision-making.
- Experience in translational research.
- Experience utilizing innovative development approaches.
Salary: The annual base salary for new hires in this position ranges $242,250 to $403,750.
Benefits: Available benefits include health care and other insurance benefits, retirement benefits, paid holidays, vacation, and paid caregiver/parental and medical leave.